Company page
Illumina, Inc.
Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.

- Ticker
- ILMN:NASDAQ
- Asset type
- Stock
- Market cap
- $29.37B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD